Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
McKesson
QuintilesIMS
Merck
Colorcon
Argus Health
UBS
Dow
Medtronic

Generated: April 21, 2018

DrugPatentWatch Database Preview

COREG Drug Profile

« Back to Dashboard

Which patents cover Coreg, and what generic alternatives are available?

Coreg is a drug marketed by Smithkline Beecham and is included in two NDAs. There are two patents protecting this drug and three Paragraph IV challenges.

The generic ingredient in COREG is carvedilol phosphate. There are thirty-six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the carvedilol phosphate profile page.
Drug patent expirations by year for COREG
Synonyms for COREG
(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol
[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine
1-((9H-Carbazol-4-yl)oxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol
1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol
1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol
102641-EP2270011A1
102641-EP2272841A1
102641-EP2275420A1
102641-EP2298764A1
102641-EP2298765A1
102641-EP2301936A1
107741-96-8
2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, (+-)-
72956-09-3
956C093
AB0008431
AB00639903_10
AB00639903_11
AB00639903_12
AB00639903-07
AB00639903-09
AB1004830
AC-1641
AC1L1E0B
AK163147
AKOS005554967
AN-14749
API0001873
Artist
Artist (TN)
Atlana Pharma brand of carvedilol
AX8120145
BBL029064
BC204100
BCP0726000253
BCP9000493
BDBM25759
BG0129
Bio-0014
BM 14,190
BM 14.190
BM 14190
BM-14-190
BM-14.190
BM-14190
BRD-A10977446-001-04-8
BRD-A10977446-045-01-1
C-21835
C06875
C24H26N2O4
Carloc (TN)
carvedilol
Carvedilol (JAN/USAN/INN)
Carvedilol [USAN:INN:BAN:JAN]
Carvedilol [USAN:USP:INN:BAN:JAN]
Carvedilol 1.0 mg/ml in Methanol
Carvedilol for system suitability, European Pharmacopoeia (EP) Reference Standard
carvedilol HCl
Carvedilol hydrochloride
Carvedilol phosphate
carvedilol, (+-)-isomer
carvedilol, (R)-isomer
carvedilol, (S)-isomer
Carvedilol, >=98% (HPLC), solid
carvedilol, 14C-labeled
Carvedilol, European Pharmacopoeia (EP) Reference Standard
Carvedilol, pharmaceutical secondary standard; traceable to USP and PhEur
Carvedilol, United States Pharmacopeia (USP) Reference Standard
Carvedilolum
Carvedilolum [Latin]
carvediol
CC-25436
CCG-100917
CCG-207952
CHEBI:3441
CHEMBL723
Coreg (TN)
Coreg CR
Coropres
Coropress
CPD000449280
CS-1194
CTK3J2232
D00255
D0W9LX
DB01136
Dibloc
Dilatrend
Dilatrend (TN)
DQ 2466
DQ-2466
DTXSID8022747
EG-P042
Eucardic
Eucardic (TN)
FT-0603059
FT-0652640
GlaxoSmithKline brand of carvedilol
GTPL551
HMS2051N03
HMS2089B09
HMS2093E12
HMS3261E15
HMS3269N11
HMS3393N03
HMS3655O14
HSDB 7044
HY-B0006
I06-0064
I06-1477
J10039
KB-75594
KBio2_002145
KBio2_004713
KBio2_007281
KBio3_002323
KBioGR_001252
KBioSS_002145
Kredex
KS-00000XRT
KS-1037
KSC492E3F
L001243
Lakeside brand of carvedilol
LP00347
LS-121875
MCULE-7944987271
MFCD00864692
MLS000758299
MLS000759508
MLS001424092
MLS006011886
MolPort-003-666-814
NC00167
NCGC00167832-01
NCGC00167832-02
NCGC00167832-03
NCGC00167832-04
NCGC00261032-01
NSC-758694
NSC758694
OGHNVEJMJSYVRP-UHFFFAOYSA-N
Pharmakon1600-01504257
PL008198
PL039781
PL068260
PubChem18218
Q-200801
Querto
Roche brand of carvedilol
RTR-037608
s1831
SAM001246736
SAM001247021
SBI-0206771.P001
SC-13445
SCHEMBL10082334
SCHEMBL13287211
SCHEMBL22293
SK&F-105517
SKF 105517
SMR000449280
SPBio_001885
Spectrum_001665
Spectrum2_001673
Spectrum3_001182
Spectrum4_000636
Spectrum5_001436
SR-01000759289
SR-01000759289-9
ST24036957
STK621453
TL8005080
Tox21_500347
TR-037608
W-5131
Z2786051695

US Patents and Regulatory Information for COREG

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smithkline Beecham COREG carvedilol TABLET;ORAL 020297-004 May 29, 1997 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Smithkline Beecham COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-002 Oct 20, 2006 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Smithkline Beecham COREG carvedilol TABLET;ORAL 020297-001 Sep 14, 1995 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Smithkline Beecham COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-004 Oct 20, 2006 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for COREG

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham COREG carvedilol TABLET;ORAL 020297-004 May 29, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Smithkline Beecham COREG carvedilol TABLET;ORAL 020297-004 May 29, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Smithkline Beecham COREG carvedilol TABLET;ORAL 020297-003 Sep 14, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Smithkline Beecham COREG carvedilol TABLET;ORAL 020297-004 May 29, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for COREG
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Extended-release Capsules 10 mg and 20 mg ➤ Subscribe 2008-03-18
➤ Subscribe Extended-release Capsules 40 mg ➤ Subscribe 2007-12-21
➤ Subscribe Extended-release Capsules 80 mg ➤ Subscribe 2007-11-19

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Cerilliant
Fish and Richardson
US Army
McKinsey
Baxter
Fuji
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.